12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok

Transplant, 12,172-183.
Anderlini,P. et al. (2008) Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning
allogeneic stem cell transplantation in relapsed and refractory Hodgkin’s lymphoma: the updated M.D. Anderson
Cancer Center experience. Haematologica 93, 257-264.
Armand. P. et al. (2008) Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-
Hodgkin lymphoma: importance of histology for outcome. Biol Blood Marrow Transplant., 14, 418-425.
Devetten, M.P., (2009) Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
for Relapsed and Refractory Hodgkin Lymphoma. Bio Blood Marrow Transplant., 15, 109-117.
Laport, G.G., (2008) Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review.
Leukemia & Lymphoma, 49, 1854-1859.
Peggs K.S. et al. (2008) Allogeneic transplantation for Hodgkin lymphoma. Br J Haematol., 143, 468-480.
Robinson, S.P. et al. (2009) Reduced intensity conditioning allogeneic stem cell translantation for Hodgkin’s
lymphoma: identification of prognostic factors predicting outcome. Haematologica, 94, 230-238.
Sureda, A. et al. (2008) Reduced-Intensity Conditioning Compared with conventional alogeneic stem-cell
transplantation in relapsed or refractory Hodgkin’s æymphoma: an analkysis from the lymphoma working party
og the European group for blood and marrow transplantation. J Clin Oncol., 26, 455-462
Thomson,K.J., et al.(2008) Superiority of reduced-intensity alogeneic transplantation over conventional
treatment for relapse of Hodgkin’s lymphoma following autologous stem cell transplantation. Bone Marrow
Transplant., 41, 765-770.
93